Kenneth Saag Selected Research

Kenneth Saag Research Topics

Disease

12	Osteoporosis 01/2021 - 11/2004
9	Gout 12/2021 - 10/2015
7	Rheumatoid Arthritis 01/2021 - 08/2002
5	Rheumatic Diseases (Rheumatism) 02/2016 - 01/2015
3	Hyperuricemia 09/2021 - 01/2018
3	Necrosis 10/2018 - 10/2016
3	Seizures (Absence Seizure) 10/2018 - 03/2013
2	Myocardial Infarction 10/2016 - 09/2008
2	Bone Resorption 08/2015 - 05/2007
2	Epilepsy (Aura) 10/2013 - 03/2013
1	Atrial Flutter (Flutter, Atrial) 12/2021
1	Atrial Fibrillation 12/2021
1	Hypertension (High Blood Pressure) 12/2020
1	Infections 10/2018
1	Pain (Aches) 11/2016
1	Inflammation (Inflammations) 11/2016
1	Hemorrhage 11/2016
1	Acute Kidney Injury (Acute Renal Failure) 11/2016
1	Coronary Disease (Coronary Heart Disease) 10/2016
1	Hip Fractures (Intertrochanteric Fractures) 10/2014
1	Femoral Fractures (Femoral Fracture) 10/2014
1	Wounds and Injuries (Trauma) 10/2014
1	Lyme Disease (Disease, Lyme) 03/2013
1	Metabolic Bone Diseases (Osteopenia) 05/2007

Drug/Important Bio-Agent (IBA)

7	Uric Acid (Urate)IBA 12/2021 - 10/2015
6	GlucocorticoidsIBA 06/2017 - 04/2009
6	Diphosphonates (Bisphosphonates)IBA 08/2015 - 11/2004
3	Collagen Type I (Type I Collagen)IBA 01/2021 - 05/2007
3	Risedronic Acid (Actonel)FDA LinkGeneric 01/2012 - 10/2008
3	Zoledronic Acid (Zometa)FDA Link 01/2012 - 05/2007
2	ProcollagenIBA 01/2021 - 04/2009
2	Allopurinol (Remid)FDA LinkGeneric 12/2020 - 05/2020
2	Rituximab (Mabthera)FDA Link 10/2018 - 06/2017
2	Xanthine OxidaseIBA 01/2018 - 12/2017
2	Pharmaceutical PreparationsIBA 01/2018 - 04/2014
2	Biological ProductsIBA 06/2017 - 10/2016
2	Methotrexate (Mexate)FDA LinkGeneric 06/2017 - 08/2002
2	Etanercept (Enbrel)FDA Link 06/2017 - 10/2016
2	Infliximab (Remicade)FDA Link 06/2017 - 10/2016
2	Abatacept (Orencia)FDA Link 06/2017 - 10/2016
2	Antirheumatic Agents (DMARD)IBA 06/2017 - 10/2016
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2016 - 09/2008
2	Anticonvulsants (Antiepileptic Drugs)IBA 10/2013 - 03/2013
2	Alendronate (Alendronate Sodium)FDA LinkGeneric 10/2008 - 05/2007
2	DONSIBA 05/2005 - 11/2004
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	Denosumab FDA Link 12/2021
1	brassIBA 01/2021
1	SteroidsIBA 10/2018
1	Febuxostat FDA Link 01/2018
1	lesinuradIBA 12/2017
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 06/2017
1	baricitinibIBA 06/2017
1	clazakizumabIBA 06/2017
1	tofacitinibIBA 06/2017
1	tocilizumab (atlizumab)FDA Link 06/2017
1	golimumab FDA Link 06/2017
1	sirukumabIBA 06/2017
1	Certolizumab Pegol FDA Link 06/2017
1	Adalimumab (Humira)FDA Link 06/2017
1	Janus Kinase InhibitorsIBA 06/2017
1	Leflunomide (Arava)FDA LinkGeneric 06/2017
1	Tumor Necrosis Factor InhibitorsIBA 06/2017
1	sarilumabIBA 06/2017
1	Janus KinasesIBA 06/2017
1	Biosimilar PharmaceuticalsIBA 06/2017
1	Diclofenac (SR 38)FDA LinkGeneric 11/2016
1	TESIBA 06/2015
1	Antinuclear AntibodiesIBA 03/2013
1	Estrogens (Estrogen)FDA Link 10/2010
1	Raloxifene Hydrochloride (Evista)FDA Link 10/2010
1	Alkaline PhosphataseIBA 04/2009
1	Teriparatide (Parathar)FDA Link 10/2008
1	Anabolic AgentsIBA 10/2008
1	Celecoxib (Celebrex)FDA Link 09/2008
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2008
1	Therapeutic UsesIBA 05/2007
1	collagen type I trimeric cross-linked peptideIBA 05/2007
1	Tacrolimus (Prograf)FDA LinkGeneric 08/2002

Therapy/Procedure

13	Therapeutics 12/2021 - 05/2007
2	Medication Errors (Medication Error) 10/2013 - 03/2013
2	Length of Stay 05/2005 - 11/2004
1	Fitness Trackers 01/2020
1	Drug Therapy (Chemotherapy) 01/2018
1	Contraindications 12/2017
1	Biological Therapy 03/2013
1	Intravenous Infusions 04/2009